止血剤・組織用シーラント市場：製品タイプ、用途、エンドユーザー別-2025-2030年の世界予測

止血剤・組織用シーラント市場の2023年の市場規模は105億米ドルで、2024年には117億8,000万米ドルに達すると予測され、CAGR 12.33％で成長し、2030年には237億2,000万米ドルに達すると予測されています。

止血剤・組織シーラント市場は、外科手術の際に出血を抑え、創傷閉鎖や組織接着を補助するために使用される器具や薬剤によって定義されます。これらの製品は、ヘルスケアにおいて術中の出血を最小限に抑え、合併症を減らし、患者の回復時間を改善するために必要です。これらの製品は、心臓血管外科、神経外科、整形外科、一般外科など、さまざまな外科領域で応用されています。主なエンドユーザーには、病院、診療所、外来手術センターなどがあります。この市場の成長は、高齢化による外科手術の増加、手術技術の進歩、世界の外傷や事故事例の増加などの影響を受けています。低侵襲手術の急増により、効果的な止血・封鎖剤に対する大きな需要が生じています。アジア太平洋やラテンアメリカの新興市場にはビジネスチャンスが豊富にあり、ヘルスケアインフラの改善により事業成長の新たな道が開けています。企業は、これらの市場を獲得するために、有効性を高め、作用時間を短縮し、副作用を低減した製品の開発に注力すべきです。

しかし、市場の成長に課題がないわけではないです。規制上のハードル、特にFDAやEMAのような機関による厳しい承認プロセスが、新製品のイントロダクションを遅らせる可能性があります。さらに、高度なシーラントに関連する高コストや、縫合糸やステープルのような従来製品との競合は、市場浸透の妨げとなる可能性があります。これらを克服するための主な技術革新分野としては、生体適合性と免疫反応の低減を約束するバイオベースの止血材の開発が挙げられます。さらに、製品の有効性と送達を改善するためのナノテクノロジーの探求は、競争上の優位性をもたらす可能性があります。市場の性質としては、頻繁な製品の上市と戦略的提携によってその情勢が形成されており、ダイナミックで競合情勢にあります。企業は、研究開発のためのパートナーシップを活用して製品ポートフォリオを充実させ、戦略的提携を結んで市場への参入を強化する一方、規制遵守を効率的に満たすために厳格な臨床試験に注力することが推奨されます。

市場力学：急速に進化する止血剤・組織用シーラント市場の主要市場インサイトを公開

止血剤・組織用シーラント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の流行とタイムリーな手術の必要性
  • 生体高分子ベースの使い捨て止血材の台頭
  • 信頼できるオンライン医療機器チャネルを通じた止血材の入手可能性
• 市場抑制要因
  • 外科用シーラントの低外形品質と高コスト
• 市場機会
  • 新世代の組織シーラントや止血剤のイントロダクション
  • 創傷治癒と閉鎖管理に焦点を当てた取り組み
• 市場の課題
  • 止血剤・組織用シーラントの使用に関する厳しい基準

ポーターの5つの力：止血剤・組織用シーラント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、止血剤・組織用シーラント市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：止血剤・組織用シーラント市場における外部からの影響の把握

外部マクロ環境要因は、止血剤・組織用シーラント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析止血剤・組織用シーラント市場における競合情勢の把握

止血剤・組織用シーラント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス止血剤・組織用シーラント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、止血剤・組織用シーラント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨止血剤・組織用シーラント市場における成功への道筋を描く

止血剤・組織用シーラント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延とタイムリーな手術の必要性
    • バイオポリマーベースの使い捨て止血材の台頭
    • 信頼できるオンライン医療機器チャネルを通じて止血剤を入手
  • 抑制要因
    • 外科用シーラントのアウトライン品質の低さとコストの高さ
  • 機会
    • 新世代の組織シーラントおよび止血剤のイントロダクション
    • 創傷治癒と閉鎖管理に焦点を当てた取り組み
  • 課題
    • 止血剤・組織用シーラントの利用に関する厳格な基準
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 止血剤・組織用シーラント市場：製品タイプ別

• 止血剤
  • アクティブ止血剤
  • 流動性止血材
  • 機械式止血鉗子
• 組織シーラント
  • フィブリンシーラント
  • 合成シーラント

第7章 止血剤・組織用シーラント市場：用途別

• 火傷および外傷の症例
• 心臓血管
• 一般外科
• 神経学的
• 整形外科
• 再建手術
• 泌尿器科

第8章 止血剤・組織用シーラント市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門クリニック

第9章 南北アメリカの止血剤・組織用シーラント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の止血剤・組織用シーラント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの止血剤・組織用シーラント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • オリンパス、欧州市場でエンドクロット止血剤および粘膜下注入剤を発売
  • コルザ・メディカル、武田薬品のタコシル製造事業買収で正式契約を締結
  • アドバメディカ社、Ax-Surgi外科用止血材のFDA認可を発表
  • 研究チームは角膜組織再建のための細胞外マトリックスベースの粘着性シーラントを開発
  • MedcuraがLifeGel（TM）吸収性外科用止血材で画期的デバイス指定を取得
  • クレシロン、シリーズA-4資金調達で2,500万米ドルを調達し、世界展開を加速、革新的な止血ジェルを人間の健康市場に投入
  • ZEISSがMTLawtonのFDA認可を取得- 電気外科手術用バイポーラ鉗子の新世代
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Advanced Medical Solutions Group PLC
• Aegis Lifesciences Private Limited.
• B. Braun SE
• Baxter International Inc.
• Becton, Dickinson and Company
• Cardinal Health, Inc.
• CooperSurgical, Inc.
• CryoLife, Inc.
• CSL Behring
• CuraMedical B.V.
• Grifols, S.A.
• Hemostasis, LLC
• Hologic, Inc.
• Integra LifeSciences Corporation
• Johnson & Johnson Services, Inc.
• KAKEN PHARMACEUTICAL CO., LTD.
• KATSAN Katgut Sanayi ve Tic. A.S.
• Medline Industries, LP.
• Medtronic PLC
• Olympus Corporation
• Owens & Minor
• Pfizer, Inc.
• Smith & Nephew PLC
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• Thermo Fisher Scientific Inc.
• Vivostat A/S
• Zimmer Biomet

LIST OF FIGURES

• FIGURE 1. HEMOSTATS & TISSUE SEALANTS MARKET RESEARCH PROCESS
• FIGURE 2. HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HEMOSTATS & TISSUE SEALANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEMOSTATS & TISSUE SEALANTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEMOSTATS & TISSUE SEALANTS MARKET DYNAMICS
• TABLE 7. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ACTIVE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FLOWABLE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY MECHANICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SYNTHETIC SEALANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY BURN & TRAUMA CASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY GENERAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY NEUROLOGICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY RECONSTRUCTIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 47. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 48. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 74. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 75. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. CHINA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 79. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 80. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 165. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 166. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. ITALY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 185. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 186. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. POLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 190. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 191. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. QATAR HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY HEMOSTATS, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY TISSUE SEALANTS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM HEMOSTATS & TISSUE SEALANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. HEMOSTATS & TISSUE SEALANTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. HEMOSTATS & TISSUE SEALANTS MARKET, FPNV POSITIONING MATRIX, 2023

The Hemostats & Tissue Sealants Market was valued at USD 10.50 billion in 2023, expected to reach USD 11.78 billion in 2024, and is projected to grow at a CAGR of 12.33%, to USD 23.72 billion by 2030.

The market for hemostats and tissue sealants is defined by devices and agents used to control bleeding and assist in wound closure or tissue adhesion during surgical procedures. These products are necessary in healthcare to minimize intraoperative blood loss, thereby reducing complications and improving patient recovery times. They find applications across various surgical disciplines, including cardiovascular, neurological, orthopedic, and general surgery. Key end-users include hospitals, clinics, and ambulatory surgical centers. Growth in this market is influenced by increasing surgical procedures due to an aging population, advancements in surgical techniques, and a rise in trauma and accident cases globally. The surge in minimally invasive procedures has created significant demand for effective hemostatic and sealing agents. Opportunities abound with emerging markets in Asia-Pacific and Latin America, where healthcare infrastructure improvements open new avenues for business growth. Companies should focus on developing products with enhanced efficacy, quicker action times, and reduced side effects to capture these markets.

However, market growth is not without challenges. Regulatory hurdles, particularly stringent approval processes from bodies like the FDA and EMA, can delay the introduction of new products. Additionally, high costs associated with advanced sealants and competition from traditional products like sutures and staples can hinder market penetration. To overcome these, key areas of innovation include the development of bio-based hemostats, which promise biocompatibility and reduced immune responses. Moreover, exploration into nanotechnology for improved product efficacy and delivery can provide competitive advantages. As for the market's nature, it is dynamic and competitive, with frequent product launches and strategic collaborations shaping its landscape. Companies are advised to leverage partnerships for R&D to boost product portfolios and engage in strategic alliances to enhance market reach while focusing on rigorous clinical trials to meet regulatory compliance efficiently.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hemostats & Tissue Sealants Market

The Hemostats & Tissue Sealants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic disorders and need for timely surgeries
  • Rise of biopolymer-based disposable hemostats
  • Availability of hemostats through trusted online medical device channels
• Market Restraints
  • Low outlining quality and high costs of surgical sealants
• Market Opportunities
  • Introduction of new-generation tissue sealants and hemostatic agents
  • Initiatives focusing on wound healing and closure management
• Market Challenges
  • Strict standards regarding the utilization of hemostats & tissue sealants

Porter's Five Forces: A Strategic Tool for Navigating the Hemostats & Tissue Sealants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hemostats & Tissue Sealants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hemostats & Tissue Sealants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hemostats & Tissue Sealants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hemostats & Tissue Sealants Market

A detailed market share analysis in the Hemostats & Tissue Sealants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hemostats & Tissue Sealants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hemostats & Tissue Sealants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hemostats & Tissue Sealants Market

A strategic analysis of the Hemostats & Tissue Sealants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hemostats & Tissue Sealants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Medical Solutions Group PLC, Aegis Lifesciences Private Limited., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., CooperSurgical, Inc., CryoLife, Inc., CSL Behring, CuraMedical B.V., Grifols, S.A., Hemostasis, LLC, Hologic, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KAKEN PHARMACEUTICAL CO., LTD., KATSAN Katgut Sanayi ve Tic. A.S., Medline Industries, LP., Medtronic PLC, Olympus Corporation, Owens & Minor, Pfizer, Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Hemostats & Tissue Sealants Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Hemostats and Tissue sealants. The Hemostats is further studied across Active Hemostats, Flowable Hemostats, and Mechanical Hemostats. The Tissue sealants is further studied across Fibrin Sealants and Synthetic Sealants.
• Based on Application, market is studied across Burn & Trauma Cases, Cardiovascular, General Surgeries, Neurological, Orthopedic, Reconstructive Surgeries, and Urological.
• Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic disorders and need for timely surgeries
    • 5.1.1.2. Rise of biopolymer-based disposable hemostats
    • 5.1.1.3. Availability of hemostats through trusted online medical device channels
  • 5.1.2. Restraints
    • 5.1.2.1. Low outlining quality and high costs of surgical sealants
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of new-generation tissue sealants and hemostatic agents
    • 5.1.3.2. Initiatives focusing on wound healing and closure management
  • 5.1.4. Challenges
    • 5.1.4.1. Strict standards regarding the utilization of hemostats & tissue sealants
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Hemostats & Tissue Sealants Market, by Product Type

• 6.1. Introduction
• 6.2. Hemostats
  • 6.2.1. Active Hemostats
  • 6.2.2. Flowable Hemostats
  • 6.2.3. Mechanical Hemostats
• 6.3. Tissue sealants
  • 6.3.1. Fibrin Sealants
  • 6.3.2. Synthetic Sealants

7. Hemostats & Tissue Sealants Market, by Application

• 7.1. Introduction
• 7.2. Burn & Trauma Cases
• 7.3. Cardiovascular
• 7.4. General Surgeries
• 7.5. Neurological
• 7.6. Orthopedic
• 7.7. Reconstructive Surgeries
• 7.8. Urological

8. Hemostats & Tissue Sealants Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Hemostats & Tissue Sealants Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Hemostats & Tissue Sealants Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Hemostats & Tissue Sealants Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets
  • 12.3.2. Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
  • 12.3.3. Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat
  • 12.3.4. Team Develops Extracellular Matrix-Based Sticky Sealants For Corneal Tissue Reconstruction
  • 12.3.5. Medcura Receives Breakthrough Device Designation for its LifeGel(TM) Absorbable Surgical Hemostat
  • 12.3.6. Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market
  • 12.3.7. ZEISS Receives FDA Clearance for MTLawton - A New Generation of Bipolar Forceps for Electrosurgery
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Advanced Medical Solutions Group PLC
• 3. Aegis Lifesciences Private Limited.
• 4. B. Braun SE
• 5. Baxter International Inc.
• 6. Becton, Dickinson and Company
• 7. Cardinal Health, Inc.
• 8. CooperSurgical, Inc.
• 9. CryoLife, Inc.
• 10. CSL Behring
• 11. CuraMedical B.V.
• 12. Grifols, S.A.
• 13. Hemostasis, LLC
• 14. Hologic, Inc.
• 15. Integra LifeSciences Corporation
• 16. Johnson & Johnson Services, Inc.
• 17. KAKEN PHARMACEUTICAL CO., LTD.
• 18. KATSAN Katgut Sanayi ve Tic. A.S.
• 19. Medline Industries, LP.
• 20. Medtronic PLC
• 21. Olympus Corporation
• 22. Owens & Minor
• 23. Pfizer, Inc.
• 24. Smith & Nephew PLC
• 25. Stryker Corporation
• 26. Teleflex Incorporated
• 27. Terumo Corporation
• 28. Thermo Fisher Scientific Inc.
• 29. Vivostat A/S
• 30. Zimmer Biomet